The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: Comorbidity burden as predictor of mortality

Europace

Volumn 13, Issue 1, 2011, Pages 62-69

  Theuns, Dominic A M J ^a   Schaer, Beat A ^a,b   Soliman, Osama I I ^a   Altmann, David ^b   Sticherling, Christian ^b   Geleijnse, Marcel L ^a   Osswald, Stefan ^b   Jordaens, Luc ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Cardiac resynchronization therapy; Comorbidity; Implantable cardioverter defibrillator; Mortality; Ventricular arrhythmia

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

AGED; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 78650464779     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq328     Document Type: Article

References (28)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with mplantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337:1576-83.
2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
3. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
5. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350: 2140-50.
6. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-49. (Pubitemid 40517094)
7. Rivero-Ayerza M, Theuns DA, Garcia-Garcia HM, Boersma E, Simoons M, Jordaens LJ. Effects of cardiac resynchronization therapy on overall mortality and mode of death: A meta-analysis of randomized controlled trials. Eur Heart J 2006;27:2682-8. (Pubitemid 44729869)
8. Goldenberg I, Moss AJ, McNitt S, ZarebaW, Andrews ML, Hall WJ et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-90.
9. Soliman OI, van Dalen BM, Theuns DA, ten Cate FJ, Nemes A, Jordaens LJ et al. The ischemic etiology of heart failure in diabetics limits reverse left ventricular remodeling after cardiac resynchronization therapy. J Diabetes Complications 2009;23:365-70.
10. Schefer T, Wolber T, Binggeli C, Holzmeister J, Brunckhorst C, Duru F. Longterm predictors of mortality in ICD patients with non-ischaemic cardiac disease: Impact of renal function. Europace 2008;10:1052-9.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83.
12. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA III, Freedman RA, Gettes LS et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;51:e1-e62.
13. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
14. Foundation NK. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002;39: S1-S266.
15. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation 1982; 65:457-64.
16. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II). J Am Coll Cardiol 2004;43:1459-65.
17. Parkash R, Stevenson WG, Epstein LM, Maisel WH. Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection. Am Heart J 2006;151:397-403.
18. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H et al. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter- defibrillators. Heart Rhythm 2009;6:468-73.
19. Bruch C, Sindermann J, Breithardt G, Gradaus R. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator. Europace 2007;9:681-6.
20. Lee DS, Tu JV, Austin PC, Dorian P, Yee R, Chong A et al. Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol 2007;49:2408-15.
21. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
22. Koller MT, Schaer B, Wolbers M, Sticherling C, Bucher HC, Osswald S. Death without prior appropriate implantable cardioverter-defibrillator therapy: A competing risk study. Circulation 2008;117:1918-26.
23. Bai R, Di Biase L, Elayi C, Ching CK, Barrett C, Philipps K et al. Mortality of heart failure patients after cardiac resynchronization therapy: Identification of predictors. J Cardiovasc Electrophysiol 2008;19:1259-65.
24. Wilkoff BL, Hess M, Young J, Abraham WT. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients. J Cardiovasc Electrophysiol 2004;15:1002-9.
25. Theuns DA, Thornton AS, Klootwijk AP, Scholten MF, Vantrimpont PJ, Balk AH et al. Outcome in patients with an ICD incorporating cardiac resynchronisation therapy: Differences between primary and secondary prophylaxis. Eur J Heart Fail 2005;7:1027-32.
26. Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW et al. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator. Circulation 2004; 110:3760-5.
27. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008;359:1009-17.
28. Lee DS, Donovan L, Austin PC, Gong Y, Liu PP, Rouleau JL et al. Comparison of coding of heart failure and comorbidities in administrative and clinical data for use in outcomes research. Med Care 2005;43:182-8.